application) Systemic hypertension is the major risk factor for coronary, cerebral and renal vascular disease. Recent studies have emphasized the role of arachidonic acid in modulating vascular contractility both through its actions on myosin phosphatase activity as well as its ability to modulate K+ channel function. The PI has demonstrated that the majority of agonist-induced release of arachidonic acid in vascular smooth cells is due to a calcium-independent phospholipase A2 which is regulated by ATP and calmodulin. Moreover, specific mechanism-based inhibition of calcium-independent phospholipase A2 results in the ablation of acetylcholine-induced relaxation of phenylephrine-constricted mesenteric arteries and ablation of agonist-induced contractile oscillatory activity. Accordingly, the overall goal of the proposed research is the identification of the molecular mechanisms through which calcium-independent phospholipase A2 participates in the regulation of vascular contractility and responsiveness.
In Specific Aim I, the molecular mechanisms through which calcium-independent phospholipase A2 facilitates nitric oxide-mediated smooth muscle vascular relaxation and oscillatory contractile activity will be identified through inhibition of calcium-independent phospholipase A2 in isolated mesenteric resistance arteries.
In Specific Aim II, the biochemical mechanisms underlying the activation of calcium-independent phospholipase A2 isoforms during agonist stimulation will be examined utilizing microbore chromatography, immunoprecipitation and phosphopeptide mapping. The molecular details of the domains of calcium-independent phospholipase A2 which mediate catalysis, activation by ATP, and interaction with calmodulin will be determined through deletional and site-directed mutagenesis.
In Specific Aim III, the role of calcium-independent phospholipase A2 in mediating the nitric oxide-induced activation of Ca2+-activated K+ channels will be examined in Sf9 cells coexpressing both K+ channel protein and calcium-independent phospholipase A2. The chemical loci through which arachidonic acid mediates its effects on the major smooth muscle K+ channels will be determined utilizing the parallel approaches of photoaffinity labeling, deletional mutagenesis and site-directed mutagenesis. Collectively, these studies constitute a multidisciplinary approach aimed at elucidating the molecular mechanisms through which calcium-independent phospholipase A2 modulates vascular contractility and responsiveness.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL041250-09
Application #
6182331
Study Section
Experimental Cardiovascular Sciences Study Section (ECS)
Project Start
1988-07-01
Project End
2002-03-31
Budget Start
2000-08-01
Budget End
2002-03-31
Support Year
9
Fiscal Year
2000
Total Cost
$289,664
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Murata, Takahiro; Dietrich, Hans H; Horiuchi, Tetsuyoshi et al. (2016) Mechanisms of magnesium-induced vasodilation in cerebral penetrating arterioles. Neurosci Res 107:57-62
Li, Anlong; Knutsen, Russell H; Zhang, Haixia et al. (2013) Hypotension due to Kir6.1 gain-of-function in vascular smooth muscle. J Am Heart Assoc 2:e000365
Murata, Takahiro; Dietrich, Hans H; Xiang, Chuanxi et al. (2013) G protein-coupled estrogen receptor agonist improves cerebral microvascular function after hypoxia/reoxygenation injury in male and female rats. Stroke 44:779-85
Liu, Xinping; Moon, Sung Ho; Mancuso, David J et al. (2013) Oxidized fatty acid analysis by charge-switch derivatization, selected reaction monitoring, and accurate mass quantitation. Anal Biochem 442:40-50
Jenkins, Christopher M; Yang, Jingyue; Gross, Richard W (2013) Mechanism-based inhibition of iPLA2? demonstrates a highly reactive cysteine residue (C651) that interacts with the active site: mass spectrometric elucidation of the mechanisms underlying inhibition. Biochemistry 52:4250-63
Osei-Owusu, Patrick; Sabharwal, Rasna; Kaltenbronn, Kevin M et al. (2012) Regulator of G protein signaling 2 deficiency causes endothelial dysfunction and impaired endothelium-derived hyperpolarizing factor-mediated relaxation by dysregulating Gi/o signaling. J Biol Chem 287:12541-9
Moon, Sung Ho; Jenkins, Christopher M; Kiebish, Michael A et al. (2012) Genetic ablation of calcium-independent phospholipase A(2)? (iPLA(2)?) attenuates calcium-induced opening of the mitochondrial permeability transition pore and resultant cytochrome c release. J Biol Chem 287:29837-50
Dietrich, Hans H (2012) Cell-to-cell communication and vascular dementia. Microcirculation 19:461-7
Moon, Sung Ho; Jenkins, Christopher M; Liu, Xinping et al. (2012) Activation of mitochondrial calcium-independent phospholipase A2? (iPLA2?) by divalent cations mediating arachidonate release and production of downstream eicosanoids. J Biol Chem 287:14880-95
Sharma, Janhavi; Turk, John; Mancuso, David J et al. (2011) Activation of group VI phospholipase A2 isoforms in cardiac endothelial cells. Am J Physiol Cell Physiol 300:C872-9

Showing the most recent 10 out of 52 publications